Dr. Tawnya Bowles, MD
Claim this profileEccles Outpatient Care Center- Oncology Clinical Trials
Studies Skin Cancer
Studies Melanoma
2 reported clinical trials
4 drugs studied
Area of expertise
1Skin Cancer
Stage IV
BRAF positive
MSI-H positive
2Melanoma
Stage IV
BRAF positive
MSI-H positive
Affiliated Hospitals
Clinical Trials Tawnya Bowles, MD is currently running
RP1 + Nivolumab
for Cancer
This trial tests a modified virus (RP1) and an immune-boosting drug (nivolumab) in adults with advanced or treatment-resistant solid tumors. RP1 kills cancer cells and helps the immune system recognize them, while nivolumab enhances the immune response. Nivolumab has been approved for treating advanced melanoma, renal cell carcinoma, non-small cell lung cancer, and other malignancies.
Recruiting1 award Phase 29 criteria
Surgical Excision Margins
for Melanoma
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.
Recruiting2 awards Phase 39 criteria
More about Tawnya Bowles, MD
Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Tawnya Bowles, MD has experience with
- Nivolumab
- RP1
- Wide Local Excision = 1cm Margin
- Wide Local Excision = 2cm Margin
Breakdown of trials Tawnya Bowles, MD has run
Microsatellite Instability
Non-melanoma Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tawnya Bowles, MD specialize in?
Tawnya Bowles, MD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Tawnya Bowles, MD currently recruiting for clinical trials?
Yes, Tawnya Bowles, MD is currently recruiting for 2 clinical trials in Murray Utah. If you're interested in participating, you should apply.
Are there any treatments that Tawnya Bowles, MD has studied deeply?
Yes, Tawnya Bowles, MD has studied treatments such as Nivolumab, RP1, Wide Local Excision = 1cm Margin.
What is the best way to schedule an appointment with Tawnya Bowles, MD?
Apply for one of the trials that Tawnya Bowles, MD is conducting.
What is the office address of Tawnya Bowles, MD?
The office of Tawnya Bowles, MD is located at: Eccles Outpatient Care Center- Oncology Clinical Trials, Murray, Utah 84107 United States. This is the address for their practice at the Eccles Outpatient Care Center- Oncology Clinical Trials.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.